WITHDRAWN: An efficient drug compound analysis model based on mutual spectral scaling feature selection using spectral deep feature classification for drug recommendation from health care
-
Published:2021-09
Issue:
Volume:
Page:100009
-
ISSN:2772-5286
-
Container-title:Neuroscience Informatics
-
language:en
-
Short-container-title:Neuroscience Informatics
Author:
Dinakaran S.,Anitha P.
Reference25 articles.
1. Shengyu Liu, Buzhou Tang, Qingcai Chen, Xiaolong Wang, Xiaoming Fan, “Feature Engineering for Drug Name Recognition in Biomedical Texts: Feature Conjunction and Feature Selection”, Computational and Mathematical Methods in Medicine, vol. 2015, Article ID 913489, 9 pages, 2015. https://doi.org/10.1155/2015/913489. 2. J. Ma, H. An, R. Zhang and R. Hu, “Collaborative Filtering based Recommendation Algorithm for Recommending Active Molecules for Protein Targets,” 2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), Madrid, Spain, 2018, pp. 1203-1208, doi: 10.1109/BIBM.2018.8621560. 3. Y. Wang, G. Deng, N. Zeng, X. Song and Y. Zhuang, “Drug-Disease Association Prediction Based on Neighborhood Information Aggregation in Neural Networks,” in IEEE Access, vol. 7, pp. 50581-50587, 2019, doi: 10.1109/ACCESS.2019.2907522. 4. J. Li, X. Ji and L. Hua, “Improving the Prediction of Adverse Drug Events Using Feature Fusion-Based Predictive Network Models,” in IEEE Access, vol. 8, pp. 48812-48821, 2020, doi: 10.1109/ACCESS.2020.2979452. 5. W. M. Czarnecki, S. Podlewska and A. J. Bojarski, “Extremely Randomized Machine Learning Methods for Compound Activity Prediction.,” Molecules, vol. 20, pp. 20107-17, 2015.
|
|